Clinical trials enter the genomic age - PMLiVE

The advent of ground-breaking genomic technologies in the clinical environment, such as Next Generation DNA Sequencing (NGS), bioinformatics and artificial intelligence, has ushered in a new era in healthcare. Every day, a gigantic amount of genomic information is generated and analysed to identify pathogenic mutations in patient DNA. This new paradigm, known as'Data-Driven Medicine', already allows clinicians to treat the causes of disease rather than its consequences and opens up new treatment opportunities for patients. This has been exemplified in cancer care where therapeutic decisions do not solely rely on morphology, but also on a patient's unique molecular profile. However, the production and analysis of patient genomic profiles is only the first part of the Data-Driven Medicine story.